JAZZ Boosts Oncology Pipeline With KRAS Inhibitor Program
https://www.zacks.com/stock/news/2223497/jazz-boosts-oncology-pipeline-with-kras-inhibitor-program?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2223497
Feb 08, 2024 - JAZZ inks a deal to acquire global rights to Redx Pharma's KRAS inhibitor program to strengthen its early-stage oncology pipeline.
0
Swig named the official Soda Shop of Utah Jazz
https://www.nrn.com/regional-chains/swig-named-official-soda-shop-utah-jazz
Feb 06, 2024 - Take note, soda fans: when the ‘jazz win, you win’ with a free swig treat the day after the game
0
'We have scouts all over the world': Former NBA All-Star Danny Ainge takes a money shot for global talent
https://www.cnbc.com/2024/01/20/former-nba-all-star-danny-ainge-sees-demand-for-international-players.html
Jan 20, 2024 - Utah Jazz CEO Danny Ainge seeks to capitalize on heightened international interest in the NBA.
0
71 Ben Graham January Value Stocks, 56 Jazzed Buys
https://seekingalpha.com/article/4660235-71-ben-graham-january-value-stocks-56-jazzed-buys?source=feed_all_articles
Dec 28, 2023 - Discover the latest insights in the financial world with this article covering value ranking strategies and top dividend stocks for investment. Click for the picks!
0
Jazz Pharmaceuticals' (JAZZ) PTSD Drug Misses Study Goals
https://www.zacks.com/stock/news/2201716/jazz-pharmaceuticals-jazz-ptsd-drug-misses-study-goals?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2201716
Dec 22, 2023 - After a mid-stage study fails to show any improvement in its primary or secondary endpoints, Jazz (JAZZ) plans to scrap the development of its PTSD drug.
0
Jazz Pharma PTSD mid-stage trial fails to meet main goal, stock slips after hours
https://seekingalpha.com/news/4049426-jazz-pharma-ptsd-mid-stage-trial-fails-to-meet-main-goal-stock-slips-after-hours?source=feed_sector_healthcare
Dec 21, 2023 - Jazz Pharmaceuticals (JAZZ) on Thursday said a mid-stage trial of JZP150 for the treatment of PTSD failed to meet the main goal of the study. Read more here.
0
Jazz presents encouraging Phase 2 data for breast cancer treatment
https://seekingalpha.com/news/4044841-jazz-presents-encouraging-phase-2-data-for-breast-cancer-treatment?source=feed_sector_healthcare
Dec 08, 2023 - Jazz Pharmaceuticals presented positive Phase 2 data for zanidatamab in the treatment of metastatic HER2+/HR+ breast cancer at a medical meeting. Read more here.
0
Why Is Jazz (JAZZ) Up 2.6% Since Last Earnings Report?
https://www.zacks.com/stock/news/2195599/why-is-jazz-jazz-up-2-6-since-last-earnings-report?cid=CS-ZC-FT-realtime_blog-2195599
Dec 08, 2023 - Jazz (JAZZ) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
0
Pages: 12
<Page 2